| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia (NCT00002638) | University of Nebraska | 1995-03-01 |
| Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00003790) | Children's Oncology Group | 1995-02-01 |
| High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies (NCT00002818) | Virginia Commonwealth University | 1995-02-01 |
| Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia (NCT00002778) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1995-02-01 |
| Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00002688) | University Medical Center Groningen | 1995-02-01 |
| Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia (NCT00002771) | German CML Study Group | 1995-01-01 |
| Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus (NCT00006340) | Boston Medical Center | 1994-12-01 |
| Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers (NCT00579163) | Memorial Sloan Kettering Cancer Center | 1994-12-01 |
| Interferon Alfa in Treating Children With HIV-Related Cancer (NCT00002621) | Children's Oncology Group | 1994-12-01 |
| Evaluation and Natural History of Children With Cancer and AIDS (NCT00001424) | National Cancer Institute (NCI) | 1994-11-01 |
| Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia (NCT00002833) | M.D. Anderson Cancer Center | 1994-10-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia (NCT00002674) | Fred Hutchinson Cancer Center | 1994-10-01 |
| Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia (NCT00528398) | City of Hope Medical Center | 1994-09-01 |
| Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia (NCT00002574) | National Cancer Institute (NCI) | 1994-09-01 |
| Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission (NCT00002609) | Memorial Sloan Kettering Cancer Center | 1994-08-01 |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia (NCT00002588) | Case Comprehensive Cancer Center | 1994-08-01 |
| Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia (NCT00002598) | Memorial Sloan Kettering Cancer Center | 1994-06-01 |
| High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission (NCT00002567) | Memorial Sloan Kettering Cancer Center | 1994-03-01 |
| Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia (NCT00002658) | Medical Research Council | 1994-01-01 |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia (NCT00002549) | European Organisation for Research and Treatment of Cancer - EORTC | 1993-11-01 |
| T-Cell Depletion in Unrelated Donor Marrow Transplantation (NCT00000591) | National Heart, Lung, and Blood Institute (NHLBI) | 1993-11-01 |
| Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse (NCT00002554) | Fred Hutchinson Cancer Center | 1993-11-01 |
| "AIDA" Protocol (LAP 0493) (NCT01064557) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 1993-10-01 |
| Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia (NCT00002592) | Abramson Cancer Center at Penn Medicine | 1993-06-01 |
| Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission (NCT00002514) | Eastern Cooperative Oncology Group | 1993-05-07 |
| Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission (NCT00002534) | Memorial Sloan Kettering Cancer Center | 1993-05-01 |
| In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients (NCT00001336) | National Cancer Institute (NCI) | 1993-04-01 |
| Bone Marrow Transplant in Treating Patients With Hematologic Cancers (NCT00005797) | H. Lee Moffitt Cancer Center and Research Institute | 1993-03-01 |
| Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00002517) | European Organisation for Research and Treatment of Cancer - EORTC | 1993-03-01 |
| Phase I Study of Intrathecal Topotecan (NCT00001333) | National Cancer Institute (NCI) | 1993-02-01 |
| New York Blood Center National Cord Blood Program (NCT00212407) | New York Blood Center | 1993-02-01 |
| Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia (NCT00002531) | Johann Wolfgang Goethe University Hospital | 1993-01-01 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia (NCT00002532) | Hannover Medical School | 1993-01-01 |
| Melphalan in Patients With Neoplastic Meningitis (NCT00002750) | Duke University | 1992-12-01 |
| Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma (NCT00018954) | National Institutes of Health Clinical Center (CC) | 1992-10-01 |
| Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies (NCT00186342) | Stanford University | 1992-09-01 |
| Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer (NCT00002504) | Hoag Memorial Hospital Presbyterian | 1992-08-01 |
| Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002502) | Memorial Sloan Kettering Cancer Center | 1992-07-01 |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia (NCT00002494) | Alliance for Clinical Trials in Oncology | 1992-05-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00060255) | Roswell Park Cancer Institute | 1991-12-01 |
| S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers (NCT00996047) | SWOG Cancer Research Network | 1991-07-01 |
| Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia (NCT00002844) | M.D. Anderson Cancer Center | 1991-03-05 |
| Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer (NCT00002553) | Fred Hutchinson Cancer Center | 1990-08-01 |
| Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00002471) | Memorial Sloan Kettering Cancer Center | 1990-02-01 |
| Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia (NCT00002499) | Grupo Argentino de Tratamiento de la Leucemia Aguda | 1990-01-01 |
| Allo BMT in Advanced Leukemia or High Grade Lymphoma (NCT00186290) | Stanford University | 1989-12-01 |
| Phase I Study of Intrathecal Mafosfamide (NCT00001251) | National Cancer Institute (NCI) | 1989-11-01 |
| Bone Marrow Grafting for Leukemia and Lymphoma (NCT00186147) | Stanford University | 1988-03-01 |
| Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome (NCT00002547) | Barbara Ann Karmanos Cancer Institute | 1987-08-01 |
| A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) (NCT01324063) | European Organisation for Research and Treatment of Cancer - EORTC | 1986-11-01 |
| Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation (NCT00002456) | Fred Hutchinson Cancer Center | 1986-05-01 |
| BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00024115) | National Cancer Institute (NCI) | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00004114) | Jonsson Comprehensive Cancer Center | |
| Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J (NCT00899015) | National Institutes of Health Clinical Center (CC) | |
| Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia (NCT00066417) | National Heart, Lung, and Blood Institute (NHLBI) | |
| Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC (NCT03145545) | Children's Hospital of Philadelphia | |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412) | M.D. Anderson Cancer Center | |
| A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00076401) | Pharmacyclics LLC. | |
| Managed Access Programs for CTL019, Tisagenlecleucel (NCT03601442) | Novartis Pharmaceuticals | |
| NOV-002 in Myelodysplastic Syndrome (MDS) (NCT00960726) | M.D. Anderson Cancer Center | |
| OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies (NCT00081055) | Mesoblast International Sàrl | |
| Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia (NCT00030355) | National Cancer Institute (NCI) | |
| Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia (NCT00004878) | Jonsson Comprehensive Cancer Center | |